Balram Bhargava - Latest News Update, Information, Photos & Videos on Balram Bhargava at Lokmat Times

The All India Institute of Medical Sciences (AIIMS) Ethics Committee on Saturday gave its approval for conducting the human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin.Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS told that the hospital will start enrolling healthy individuals from Monday onwards."Today, we got approval from AIIMS Ethics Committee for starting the human clinical trial of the indigenously developed Covaxin. We are launching the enrollment process from Monday. We are going to select healthy participants with no comorbidities and without a history of COVID-19. The age group of the study population is 18 to 55 years. This would be a randomised, double-blind, placebo-controlled clinical trial," Dr Rai told .The country's top drug regulator had recently gave a green signal for human clinical trials for COVID-19 vaccine candidate Covaxin, which has been developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV).Asked about the concerns raised by AIIMS Ethics Committee a few days back regarding the trial, Dr Rai said that those concerns were addressed in the Ethics Committee meeting and the panel gave green signal to initiate the trial."Any healthy individual who wishes to participate in the trial can send in an email on Ctaiims.covid19@gmail.com or send an SMS or call on 7428847499," he said, adding that in the first and second phase AIIMS (Delhi) will choose only 100 participants out of 375 volunteers and the remaining will participate at other sites."We have already registered a few volunteers for the trial. From Monday onwards, our team will start their health screening before giving them vaccination," he said.It may be noted that there are 12 places where the trial for Covaxin is taking place as per the Indian Council for Medical Research (ICMR).Trials have started at AIIMS, Patna and few other places.had cited Director General of Indian Council of Medical Research (ICMR) Dr Balram Bhargava as saying on July 14 that as far as coronavirus pandemic is concerned the country has two indigenous candidate vaccines which scientists are trying best efforts to fast-track as their moral duty so that there should not be a delay of a single day for regulatory clearances for these vaccines to break the transmission of the virus as soon as possible."There are two Indian indigenous candidate vaccines and they have gone successful toxicity studies in rats, mice and rabbits. The data was submitted to the Drugs Controller General of India (DCGI) following which both these candidate vaccines got clearance to start the early phase of human trials," he had said.had also reported that DCGI has given its permission to pharma giant Zydus Cadila besides Bharat Biotech International Limited (BBIL), which had partnered with ICMR to conduct phase I/II clinical trials on humans for COVId -19 vaccine.( With inputs from ANI )

Balram BhargavaFOLLOW

Balram bhargava, Latest News

New Delhi, Sep 15 Lauding the nation-wide lockdown, ICMR Director General Balram Bhargava on Tuesday said that the ... ...

New Delhi, Sep 15 The Health Ministry on Tuesday clarified that there is no dearth of medical oxygen ... ...

Union Health Ministry on Thursday said there are states where RT-PCR testing capacity for COVID-19 is not being utilised to its optimal capacity. ...

Shortly after announcing the first COVID-19 vaccine, Russian President Vladimir Putin on Tuesday said that his daughter, who was given a shot of the vaccine, had developed a slight fever but then recovered and now her antibody titers are high. ...

New Delhi, Aug 5 Drug firm Zydus Cadila on Wednesday announced that its plasmid DNA vaccine to prevent COVID-19 ... ...

While as many as 141 COVID-19 vaccine candidates are being studied by the scientists across the globe, India has three vaccine candidates which are in different phases of the clinical study, top ICMR scientist (Prof) Balram Bhargava informed on Tuesd ...

New Delhi, Aug 4 The Union Health Ministry on Tuesday said that as many as 18,000 ventilators have ... ...

The All India Institute of Medical Sciences (AIIMS) Ethics Committee on Saturday gave its approval for conducting the human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin. ...